Mathias Montenarh Selected Research

Mathias Montenarh Research Topics

Disease

19	Neoplasms (Cancer) 04/2022 - 10/2004
6	Prostatic Neoplasms (Prostate Cancer) 07/2012 - 06/2003
4	Colonic Neoplasms (Colon Cancer) 06/2014 - 10/2004
4	Carcinoma (Carcinomatosis) 08/2006 - 11/2002
2	Inflammation (Inflammations) 01/2016 - 10/2015
1	Insulin Resistance 09/2019
1	Diabetes Mellitus 09/2019
1	Ischemia 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Thrombosis (Thrombus) 11/2015
1	Leukemia 02/2014
1	Endometriosis 06/2012
1	Melanoma (Melanoma, Malignant) 01/2012
1	Type 2 Diabetes Mellitus (MODY) 04/2008
1	Ovarian Neoplasms (Ovarian Cancer) 08/2006
1	Retinal Neovascularization 05/2006
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 05/2006
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2006
1	Angiofibroma 01/2006
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2005
1	Breast Neoplasms (Breast Cancer) 07/2005
1	Retinoblastoma (Glioblastoma, Retinal) 03/2005
1	Colorectal Neoplasms (Colorectal Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 07/2017 - 10/2004
6	Casein Kinase II (Casein Kinase 2)IBA 01/2016 - 06/2003
4	Phosphotransferases (Kinase)IBA 10/2015 - 06/2009
3	Hormones (Hormone)IBA 07/2012 - 06/2003
3	AntibodiesIBA 05/2006 - 10/2004
2	AntigensIBA 04/2022 - 10/2004
2	coumarinIBA 07/2017 - 02/2012
2	cdc25 PhosphatasesIBA 07/2017 - 10/2011
2	E-SelectinIBA 01/2016 - 10/2015
2	Retinaldehyde (Retinal)IBA 06/2014 - 05/2006
2	diallyl tetrasulfideIBA 11/2013 - 03/2012
2	Messenger RNA (mRNA)IBA 01/2012 - 01/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 07/2005
2	4,5,6,7-tetrabromobenzotriazoleIBA 01/2011 - 05/2006
2	beta CateninIBA 12/2007 - 01/2006
2	Androgen Receptors (Androgen Receptor)IBA 02/2007 - 01/2006
2	EpitopesIBA 02/2006 - 10/2004
2	AutoantibodiesIBA 02/2006 - 10/2004
1	Proteoglycans (Proteoglycan)IBA 04/2022
1	Insulin (Novolin)FDA Link 09/2019
1	Protein Kinases (Protein Kinase)IBA 09/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2017
1	QuinolonesIBA 07/2017
1	Cell Adhesion MoleculesIBA 01/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2015
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2015
1	Transcription Factor CHOPIBA 07/2014
1	SeleniumIBA 06/2014
1	TelluriumIBA 06/2014
1	Biological ProductsIBA 02/2014
1	CaspasesIBA 02/2014
1	AntioxidantsIBA 11/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013
1	Sulfhydryl Compounds (Thiols)IBA 11/2013
1	4,5,6,7-tetrabromobenzimidazoleIBA 07/2012
1	BenzimidazolesIBA 07/2012
1	1,2,5,8-tetrahydroxy anthraquinoneIBA 06/2012
1	diallyl trisulfideIBA 03/2012
1	MicroRNAs (MicroRNA)IBA 01/2012
1	MethyltransferasesIBA 01/2012
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2012
1	Azacitidine (5 Azacytidine)FDA Link 01/2012
1	Histone Deacetylase InhibitorsIBA 01/2012
1	trichostatin A (A 300)IBA 01/2012
1	theasinensin AIBA 01/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2012
1	1,25-dihydroxyvitamin DIBA 01/2012
1	Vitamin D FDA LinkGeneric 01/2012
1	Sulfur Compounds (Compounds, Sulfur)IBA 05/2009
1	pancreatic and duodenal homeobox 1 proteinIBA 04/2008
1	Gemcitabine FDA Link 08/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2006
1	Cisplatin (Platino)FDA LinkGeneric 08/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2006
1	Emodin (Archin)IBA 05/2006
1	Peptide LibraryIBA 02/2006
1	Monoclonal AntibodiesIBA 02/2006
1	Peptides (Polypeptides)IBA 02/2006
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2005
1	Retinoblastoma ProteinIBA 03/2005
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2002

Therapy/Procedure

9	Therapeutics 09/2019 - 02/2006
2	Drug Therapy (Chemotherapy) 05/2009 - 08/2006
1	Chemoprevention 05/2009
1	Lasers (Laser) 01/2006